(Q42661770)

4 November 2017

title

Do gender, age or lifestyle factors affect responses to antimuscarinic treatment in overactive bladder patients? (English)

1 reference

4 November 2017

T Schneider

1

1 reference

4 November 2017

D Marschall-Kehrel

series ordinal

2

1 reference

4 November 2017

J U Hanisch

series ordinal

3

1 reference

4 November 2017

M C Michel

series ordinal

4

1 reference

4 November 2017

publication date

24 May 2010

1 reference

International Journal of Clinical Practice

4 November 2017

published in

1 reference

4 November 2017

volume

64

1 reference

4 November 2017

issue

9

1 reference

4 November 2017

page(s)

1287-1293

1 reference

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Basic mechanisms of urgency: preclinical and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Dietary caffeine intake and the risk for detrusor instability: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

The effects of lifestyle factors on the incidence of nocturia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

The association of diet and other lifestyle factors with the onset of overactive bladder: a longitudinal study in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

How should patients with an overactive bladder manipulate their fluid intake?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Effects of obesity and weight loss in patients with nononcological urological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Physiological and pathological regulation of the autonomic control of urinary bladder contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Treatment of overactive bladder in the older patient: pooled analysis of three phase III studies of darifenacin, an M3 selective receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02442.X

10.1111/J.1742-1241.2010.02442.X

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference